Cannara Biotech Stock Price History
LOVE Stock | CAD 0.80 0.12 17.65% |
Below is the normalized historical share price chart for Cannara Biotech extending back to January 14, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Cannara Biotech stands at 0.80, as last reported on the 20th of December, with the highest price reaching 0.80 and the lowest price hitting 0.67 during the day.
If you're considering investing in Cannara Stock, it is important to understand the factors that can impact its price. Cannara Biotech appears to be out of control, given 3 months investment horizon. Cannara Biotech secures Sharpe Ratio (or Efficiency) of 0.0949, which signifies that the company had a 0.0949% return per unit of risk over the last 3 months. By analyzing Cannara Biotech's technical indicators, you can evaluate if the expected return of 0.59% is justified by implied risk. Please makes use of Cannara Biotech's Downside Deviation of 6.8, risk adjusted performance of 0.0734, and Mean Deviation of 4.28 to double-check if our risk estimates are consistent with your expectations.
Other Stockholder Equity is likely to climb to about 18.3 K in 2024, whereas Total Stockholder Equity is likely to drop slightly above 57 M in 2024. . At this time, Cannara Biotech's Price Earnings Ratio is fairly stable compared to the past year. Price To Operating Cash Flows Ratio is likely to climb to 6.02 in 2024, whereas Price Book Value Ratio is likely to drop 0.66 in 2024. Cannara Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 0.7261 | 50 Day MA 0.6912 | Beta 1.072 |
Cannara |
Sharpe Ratio = 0.0949
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | LOVE | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
6.18 actual daily | 55 55% of assets are less volatile |
Expected Return
0.59 actual daily | 11 89% of assets have higher returns |
Risk-Adjusted Return
0.09 actual daily | 7 93% of assets perform better |
Based on monthly moving average Cannara Biotech is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cannara Biotech by adding it to a well-diversified portfolio.
Price Book 0.8188 | Enterprise Value Ebitda 7.4993 | Price Sales 0.9391 | Shares Float 44 M | Earnings Share 0.07 |
Cannara Biotech Stock Price History Chart
There are several ways to analyze Cannara Stock price data. The simplest method is using a basic Cannara candlestick price chart, which shows Cannara Biotech price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | December 2, 2024 | 0.83 |
Lowest Price | October 2, 2024 | 0.59 |
Cannara Biotech December 20, 2024 Stock Price Synopsis
Various analyses of Cannara Biotech's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Cannara Stock. It can be used to describe the percentage change in the price of Cannara Biotech from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Cannara Stock.Cannara Biotech Price Daily Balance Of Power | 0.92 | |
Cannara Biotech Price Action Indicator | 0.13 | |
Cannara Biotech Price Rate Of Daily Change | 1.18 |
Cannara Biotech December 20, 2024 Stock Price Analysis
Cannara Stock Price History Data
The price series of Cannara Biotech for the period between Sat, Sep 21, 2024 and Fri, Dec 20, 2024 has a statistical range of 0.24 with a coefficient of variation of 9.23. The daily prices for the period are spread out with arithmetic mean of 0.68. The median price for the last 90 days is 0.66. The company underwent 1:10 stock split on 13th of February 2023.Open | High | Low | Close | Volume | ||
12/20/2024 | 0.67 | 0.80 | 0.67 | 0.80 | ||
12/19/2024 | 0.67 | 0.80 | 0.67 | 0.80 | 65,613 | |
12/18/2024 | 0.68 | 0.70 | 0.66 | 0.68 | 11,500 | |
12/17/2024 | 0.68 | 0.68 | 0.68 | 0.68 | 6,204 | |
12/16/2024 | 0.71 | 0.71 | 0.71 | 0.71 | 6,988 | |
12/13/2024 | 0.71 | 0.72 | 0.71 | 0.72 | 12,006 | |
12/12/2024 | 0.73 | 0.73 | 0.65 | 0.65 | 28,152 | |
12/11/2024 | 0.80 | 0.80 | 0.80 | 0.80 | 1.00 | |
12/10/2024 | 0.72 | 0.80 | 0.70 | 0.80 | 18,500 | |
12/09/2024 | 0.75 | 0.75 | 0.70 | 0.75 | 46,929 | |
12/06/2024 | 0.75 | 0.75 | 0.75 | 0.75 | 13,500 | |
12/05/2024 | 0.75 | 0.75 | 0.75 | 0.75 | 7,250 | |
12/04/2024 | 0.76 | 0.77 | 0.76 | 0.77 | 9,000 | |
12/03/2024 | 0.82 | 0.82 | 0.77 | 0.77 | 18,900 | |
12/02/2024 | 0.76 | 0.83 | 0.76 | 0.83 | 62,640 | |
11/29/2024 | 0.77 | 0.79 | 0.77 | 0.79 | 8,604 | |
11/28/2024 | 0.71 | 0.75 | 0.71 | 0.75 | 19,500 | |
11/27/2024 | 0.69 | 0.70 | 0.69 | 0.70 | 1,398 | |
11/26/2024 | 0.73 | 0.73 | 0.72 | 0.72 | 8,035 | |
11/25/2024 | 0.68 | 0.78 | 0.68 | 0.78 | 57,127 | |
11/22/2024 | 0.68 | 0.68 | 0.68 | 0.68 | 1.00 | |
11/21/2024 | 0.68 | 0.68 | 0.68 | 0.68 | 5,510 | |
11/20/2024 | 0.65 | 0.67 | 0.65 | 0.67 | 27,160 | |
11/19/2024 | 0.59 | 0.59 | 0.59 | 0.59 | 3,560 | |
11/18/2024 | 0.62 | 0.62 | 0.60 | 0.61 | 9,179 | |
11/15/2024 | 0.61 | 0.61 | 0.61 | 0.61 | 3,000 | |
11/14/2024 | 0.60 | 0.60 | 0.58 | 0.60 | 7,747 | |
11/13/2024 | 0.61 | 0.63 | 0.59 | 0.63 | 7,855 | |
11/12/2024 | 0.60 | 0.60 | 0.60 | 0.60 | 4,960 | |
11/11/2024 | 0.60 | 0.62 | 0.60 | 0.62 | 60,157 | |
11/08/2024 | 0.65 | 0.66 | 0.65 | 0.66 | 3,000 | |
11/07/2024 | 0.62 | 0.68 | 0.62 | 0.68 | 6,014 | |
11/06/2024 | 0.75 | 0.75 | 0.62 | 0.65 | 81,614 | |
11/05/2024 | 0.75 | 0.75 | 0.75 | 0.75 | 27,550 | |
11/04/2024 | 0.70 | 0.76 | 0.70 | 0.75 | 23,641 | |
11/01/2024 | 0.70 | 0.70 | 0.70 | 0.70 | 2,624 | |
10/31/2024 | 0.79 | 0.79 | 0.70 | 0.70 | 6,850 | |
10/30/2024 | 0.68 | 0.79 | 0.68 | 0.79 | 46,036 | |
10/29/2024 | 0.72 | 0.80 | 0.70 | 0.70 | 71,427 | |
10/28/2024 | 0.67 | 0.73 | 0.66 | 0.70 | 110,138 | |
10/25/2024 | 0.64 | 0.67 | 0.64 | 0.67 | 144,401 | |
10/24/2024 | 0.64 | 0.64 | 0.64 | 0.64 | 1.00 | |
10/23/2024 | 0.63 | 0.64 | 0.62 | 0.64 | 11,216 | |
10/22/2024 | 0.61 | 0.61 | 0.61 | 0.61 | 500.00 | |
10/21/2024 | 0.64 | 0.64 | 0.62 | 0.62 | 4,700 | |
10/18/2024 | 0.64 | 0.64 | 0.63 | 0.63 | 5,500 | |
10/17/2024 | 0.64 | 0.64 | 0.64 | 0.64 | 1.00 | |
10/16/2024 | 0.63 | 0.64 | 0.63 | 0.64 | 2,637 | |
10/15/2024 | 0.64 | 0.65 | 0.64 | 0.64 | 8,578 | |
10/11/2024 | 0.64 | 0.64 | 0.64 | 0.64 | 500.00 | |
10/10/2024 | 0.62 | 0.62 | 0.62 | 0.62 | 1.00 | |
10/09/2024 | 0.62 | 0.62 | 0.62 | 0.62 | 600.00 | |
10/08/2024 | 0.64 | 0.64 | 0.64 | 0.64 | 1.00 | |
10/07/2024 | 0.64 | 0.64 | 0.64 | 0.64 | 5,269 | |
10/04/2024 | 0.59 | 0.66 | 0.59 | 0.66 | 9,575 | |
10/03/2024 | 0.60 | 0.60 | 0.60 | 0.60 | 2,000 | |
10/02/2024 | 0.62 | 0.62 | 0.57 | 0.59 | 34,164 | |
10/01/2024 | 0.62 | 0.62 | 0.61 | 0.61 | 6,101 | |
09/30/2024 | 0.63 | 0.65 | 0.61 | 0.61 | 6,407 | |
09/27/2024 | 0.63 | 0.63 | 0.63 | 0.63 | 500.00 | |
09/26/2024 | 0.66 | 0.66 | 0.66 | 0.66 | 1.00 |
About Cannara Biotech Stock history
Cannara Biotech investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cannara is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cannara Biotech will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cannara Biotech stock prices may prove useful in developing a viable investing in Cannara Biotech
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 81.3 M | 77.2 M | |
Net Income Applicable To Common Shares | 2.7 M | 2.8 M |
Cannara Biotech Stock Technical Analysis
Cannara Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Pattern Recognition Now
Pattern RecognitionUse different Pattern Recognition models to time the market across multiple global exchanges |
All Next | Launch Module |
Cannara Biotech Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cannara Biotech's price direction in advance. Along with the technical and fundamental analysis of Cannara Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cannara to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0734 | |||
Jensen Alpha | 0.4839 | |||
Total Risk Alpha | 0.3104 | |||
Sortino Ratio | 0.069 | |||
Treynor Ratio | 1.36 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Cannara Stock Analysis
When running Cannara Biotech's price analysis, check to measure Cannara Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cannara Biotech is operating at the current time. Most of Cannara Biotech's value examination focuses on studying past and present price action to predict the probability of Cannara Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cannara Biotech's price. Additionally, you may evaluate how the addition of Cannara Biotech to your portfolios can decrease your overall portfolio volatility.